Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · IEX Real-Time Price · USD
32.26
+0.22 (0.67%)
Jul 22, 2024, 10:29 AM EDT - Market open

HRMY Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Market Capitalization
1,8351,8923,2682,4932,057-
Market Cap Growth
-2.07%-42.12%31.09%21.23%--
Enterprise Value
1,6371,7323,1372,4512,02273
PE Ratio
13.8714.6818.0172.07-32.21-
PS Ratio
2.953.257.478.1612.87-
PB Ratio
3.534.058.1113.3721.16-
P/FCF Ratio
8.768.6422.6525.37-688.50-
P/OCF Ratio
8.758.6222.6225.30-688.96-
EV/Sales Ratio
2.652.987.168.0212.6612.26
EV/EBITDA Ratio
6.897.8221.3630.461336.52-0.52
EV/EBIT Ratio
7.688.7825.4039.77-231.79-0.50
EV/FCF Ratio
7.887.9121.7424.94-676.99-0.97
Debt / Equity Ratio
0.370.410.481.032.00-0.23
Debt / EBITDA Ratio
0.800.871.302.39128.39-0.69
Debt / FCF Ratio
0.910.881.331.95-65.03-1.30
Quick Ratio
2.932.614.795.011.861.44
Current Ratio
3.112.755.075.291.951.58
Asset Turnover
0.770.760.770.800.600.06
Interest Coverage
8.318.306.572.55-0.31-24.03
Return on Equity (ROE)
28.30%27.50%60.10%24.20%39.20%56.30%
Return on Assets (ROA)
17.20%16.80%31.70%9.10%-23.90%-191.00%
Return on Capital (ROIC)
21.21%21.60%35.04%21.38%5.83%44.91%
Earnings Yield
7.57%6.81%5.55%1.39%-3.10%-
FCF Yield
11.41%11.58%4.41%3.94%-0.15%-
Buyback Yield / Dilution
5.92%1.19%-3.20%-129.72%-231.37%12.19%
Total Shareholder Return
5.92%1.19%-3.20%-129.72%-231.37%12.19%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).